• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄和原发感染性质对水痘-带状疱疹病毒特异性细胞免疫应答的影响。

Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.

机构信息

Department of Pediatrics, University of Colorado Denver, Aurora, Colorado, USA.

出版信息

J Infect Dis. 2010 Apr 1;201(7):1024-30. doi: 10.1086/651199.

DOI:10.1086/651199
PMID:20170376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3136368/
Abstract

BACKGROUND

Varicella-zoster virus (VZV)-specific cell-mediated immunity is important for protection against VZV disease. We studied the relationship between VZV cell-mediated immunity and age after varicella or VZV vaccination in healthy and human immunodeficiency virus (HIV)-infected individuals.

METHODS

VZV responder cell frequency (RCF) determinations from 752 healthy and 200 HIV-infected subjects were used to identify group-specific regression curves on age.

RESULTS

In healthy individuals with past varicella, VZV RCF peaked at 34 years of age. Similarly, VZV-RCF after varicella vaccine increased with age in subjects aged <1 to 43 years. In subjects aged 61-90 years, VZV RCF after zoster vaccine decreased with age. HIV-infected children had lower VZV RCF estimates than HIV-infected adults. In both groups, VZV RCF results were low and constant over age. Varicella vaccination of HIV-infected children with CD4 levels 20% generated VZV RCF values higher than wild-type infection and comparable to vaccine-induced responses of healthy children.

CONCLUSIONS

In immunocompetent individuals with prior varicella, VZV RCF peaked in early adulthood. Administration of varicella vaccine to HIV-infected or uninfected individuals aged >5 years generated VZV RCF values similar to those of immunocompetent individuals with immunity induced by wild-type infection. A zoster vaccine increased the VZV RCF of elderly adults aged <75 years to values higher than peak values induced by wild-type infection.

摘要

背景

水痘带状疱疹病毒(VZV)特异性细胞介导的免疫对于预防 VZV 疾病至关重要。我们研究了在健康个体和人类免疫缺陷病毒(HIV)感染者中,水痘或 VZV 疫苗接种后 VZV 细胞介导免疫与年龄的关系。

方法

我们对 752 名健康个体和 200 名 HIV 感染者的 VZV 反应细胞频率(RCF)进行了测定,以确定年龄的组特异性回归曲线。

结果

在有既往水痘病史的健康个体中,VZV RCF 在 34 岁时达到峰值。同样,在年龄<1 至 43 岁的个体中,水痘疫苗后的 VZV-RCF 随着年龄的增长而增加。在年龄 61-90 岁的个体中,带状疱疹疫苗后的 VZV RCF 随着年龄的增长而下降。HIV 感染儿童的 VZV RCF 估计值低于 HIV 感染成人。在这两个群体中,VZV RCF 结果随着年龄的增长而保持低值且稳定。对 CD4 水平为 20%的 HIV 感染儿童进行水痘疫苗接种可产生高于野生型感染的 VZV RCF 值,与健康儿童的疫苗诱导反应相当。

结论

在有既往水痘病史的免疫功能正常个体中,VZV RCF 在成年早期达到峰值。对年龄>5 岁的 HIV 感染者或未感染者接种水痘疫苗可产生与免疫功能正常个体的野生型感染诱导的 VZV RCF 值相似的 VZV RCF 值。带状疱疹疫苗可将年龄<75 岁的老年个体的 VZV RCF 提高到高于野生型感染诱导的峰值水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f18a/3136368/d82187d636ab/nihms-188857-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f18a/3136368/c603dff9fb68/nihms-188857-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f18a/3136368/9e8be47b46de/nihms-188857-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f18a/3136368/d82187d636ab/nihms-188857-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f18a/3136368/c603dff9fb68/nihms-188857-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f18a/3136368/9e8be47b46de/nihms-188857-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f18a/3136368/d82187d636ab/nihms-188857-f0003.jpg

相似文献

1
Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.年龄和原发感染性质对水痘-带状疱疹病毒特异性细胞免疫应答的影响。
J Infect Dis. 2010 Apr 1;201(7):1024-30. doi: 10.1086/651199.
2
Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine.一项随机对照试验的方案,该试验旨在表征肯尼亚健康女性接种水痘带状疱疹病毒(VZV)疫苗所诱导的免疫反应:为潜在的基于VZV的HIV疫苗奠定基础。
BMJ Open. 2017 Sep 21;7(9):e017391. doi: 10.1136/bmjopen-2017-017391.
3
Safety and immunogenicity of a live attenuated varicella vaccine in VZV-seropositive HIV-infected adults.减毒活水痘疫苗在水痘带状疱疹病毒血清阳性的HIV感染成人中的安全性和免疫原性。
Hum Vaccin. 2010 Apr;6(4):318-21. doi: 10.4161/hv.6.4.10654. Epub 2010 Apr 15.
4
CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.CD4 T 细胞免疫对于控制猴痘病毒感染的非人类灵长类动物模型中的猴痘病毒感染至关重要。
PLoS Pathog. 2011 Nov;7(11):e1002367. doi: 10.1371/journal.ppat.1002367. Epub 2011 Nov 10.
5
Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.给目前或过去CD4(+) T细胞显著减少的HIV感染儿童接种水痘活疫苗。
J Infect Dis. 2006 Jul 15;194(2):247-55. doi: 10.1086/505149. Epub 2006 Jun 14.
6
A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.一项关于活减毒水痘带状疱疹病毒疫苗的 I- II 期研究,旨在增强既往患过水痘的人类免疫缺陷病毒感染儿童的免疫力。
Pediatr Infect Dis J. 2009 Jul;28(7):653-5. doi: 10.1097/INF.0b013e3181998f06.
7
Immune responses to varicella-zoster virus.对水痘-带状疱疹病毒的免疫反应。
Infect Dis Clin North Am. 1996 Sep;10(3):529-70. doi: 10.1016/s0891-5520(05)70312-3.
8
Varicella vaccination in HIV-1-infected children after immune reconstitution.免疫重建后HIV-1感染儿童的水痘疫苗接种
AIDS. 2006 Nov 28;20(18):2321-9. doi: 10.1097/QAD.0b013e3280113f29.
9
Proliferative response to varicella-zoster virus is inverse related to development of high levels of varicella-zoster virus specific IgG antibodies.对水痘-带状疱疹病毒的增殖反应与高水平水痘-带状疱疹病毒特异性IgG抗体的产生呈负相关。
Scand J Infect Dis. 1993;25(6):775-8. doi: 10.3109/00365549309008578.
10
Varicella immunity in vaccinated healthcare workers.接种疫苗的医护人员的水痘免疫力。
J Clin Virol. 2013 Jun;57(2):109-14. doi: 10.1016/j.jcv.2013.01.015. Epub 2013 Feb 20.

引用本文的文献

1
Seroprevalence of Varicella-Zoster Virus and the Need for Herpes Zoster Vaccination Among Adults in Saudi Arabia.沙特阿拉伯成年人中水痘-带状疱疹病毒血清阳性率及带状疱疹疫苗接种需求
Cureus. 2025 Mar 21;17(3):e80949. doi: 10.7759/cureus.80949. eCollection 2025 Mar.
2
The surveillance of viral infections by the unconventional Type I NKT cell.非常规I型自然杀伤T细胞对病毒感染的监测。
Front Immunol. 2024 Sep 17;15:1472854. doi: 10.3389/fimmu.2024.1472854. eCollection 2024.
3
Lipo-pam™ adjuvanted herpes zoster vaccine induces potent gE-specific cellular and humoral immune responses.

本文引用的文献

1
Safety and immunogenicity of a live attenuated varicella vaccine in VZV-seropositive HIV-infected adults.减毒活水痘疫苗在水痘带状疱疹病毒血清阳性的HIV感染成人中的安全性和免疫原性。
Hum Vaccin. 2010 Apr;6(4):318-21. doi: 10.4161/hv.6.4.10654. Epub 2010 Apr 15.
2
Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.在一项临床有效的带状疱疹疫苗试验中,老年参与者对带状疱疹的水痘-带状疱疹病毒特异性免疫反应。
J Infect Dis. 2009 Oct 1;200(7):1068-77. doi: 10.1086/605611.
3
A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.
Lipo-pam™ 佐剂带状疱疹疫苗可诱导产生强效的gE特异性细胞免疫和体液免疫反应。
NPJ Vaccines. 2024 Aug 17;9(1):150. doi: 10.1038/s41541-024-00939-4.
4
A nanoparticle vaccine displaying varicella-zoster virus gE antigen induces a superior cellular immune response than a licensed vaccine in mice and non-human primates.一种展示水痘带状疱疹病毒 gE 抗原的纳米颗粒疫苗在小鼠和非人类灵长类动物中诱导出比许可疫苗更优的细胞免疫应答。
Front Immunol. 2024 Jul 16;15:1419634. doi: 10.3389/fimmu.2024.1419634. eCollection 2024.
5
Trained Immunity Generated by the Recombinant Zoster Vaccine.重组带状疱疹疫苗产生的训练免疫
Res Sq. 2024 Jul 10:rs.3.rs-4607744. doi: 10.21203/rs.3.rs-4607744/v1.
6
CD4/CD8 Ratio: An Independent Predictor of Herpes Zoster in Patients With Autoimmune Inflammatory Rheumatic Diseases.CD4/CD8 比值:自身免疫性炎性风湿性疾病患者带状疱疹的独立预测指标
Ann Dermatol. 2024 Jun;36(3):163-171. doi: 10.5021/ad.23.126.
7
Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review.减毒活疫苗和重组/灭活水痘带状疱疹疫苗在HIV感染者中的免疫原性和安全性:一项系统评价
Hum Vaccin Immunother. 2024 Dec 31;20(1):2341456. doi: 10.1080/21645515.2024.2341456. Epub 2024 Apr 22.
8
Herpes Zoster and Cardiovascular Disease: Exploring Associations and Preventive Measures through Vaccination.带状疱疹与心血管疾病:通过接种疫苗探索关联及预防措施
Vaccines (Basel). 2024 Feb 28;12(3):252. doi: 10.3390/vaccines12030252.
9
Associations between Different Antivirals and Hospital-Acquired Acute Kidney Injury in Adults with Herpes Zoster.不同抗病毒药物与带状疱疹成人患者医院获得性急性肾损伤的关联。
Clin J Am Soc Nephrol. 2024 Jun 1;19(6):694-703. doi: 10.2215/CJN.0000000000000452. Epub 2024 Mar 26.
10
Advances in understanding the mechanism of action of adult vaccines.成人疫苗作用机制研究进展。
J Clin Invest. 2023 Dec 1;133(23):e175378. doi: 10.1172/JCI175378.
一项关于活减毒水痘带状疱疹病毒疫苗的 I- II 期研究,旨在增强既往患过水痘的人类免疫缺陷病毒感染儿童的免疫力。
Pediatr Infect Dis J. 2009 Jul;28(7):653-5. doi: 10.1097/INF.0b013e3181998f06.
4
The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.水痘疫苗接种后儿童和青少年带状疱疹的发病率和临床特征。
Pediatr Infect Dis J. 2009 Nov;28(11):954-9. doi: 10.1097/INF.0b013e3181a90b16.
5
Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.高效抗逆转录病毒疗法对感染HIV儿童带状疱疹发病率的短期和长期影响。
J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):182-91. doi: 10.1097/QAI.0b013e31819550a4.
6
Primary vaccine failure after 1 dose of varicella vaccine in healthy children.健康儿童接种一剂水痘疫苗后出现原发性疫苗失败。
J Infect Dis. 2008 Apr 1;197(7):944-9. doi: 10.1086/529043.
7
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.带状疱疹疫苗老年接种者中的水痘-带状疱疹病毒特异性免疫反应。
J Infect Dis. 2008 Mar 15;197(6):825-35. doi: 10.1086/528696.
8
Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.水痘的预防:儿童使用水痘疫苗的建议,包括常规2剂水痘免疫接种程序的建议。
Pediatrics. 2007 Jul;120(1):221-31. doi: 10.1542/peds.2007-1089.
9
Loss of vaccine-induced immunity to varicella over time.随着时间推移,疫苗诱导的水痘免疫力丧失。
N Engl J Med. 2007 Mar 15;356(11):1121-9. doi: 10.1056/NEJMoa064040.
10
Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.给目前或过去CD4(+) T细胞显著减少的HIV感染儿童接种水痘活疫苗。
J Infect Dis. 2006 Jul 15;194(2):247-55. doi: 10.1086/505149. Epub 2006 Jun 14.